Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Ceramides Drive RGNNV Replication Through Autophagy
2026-09-01
This study uses global lipidomics and targeted perturbation experiments to show that red-spotted grouper nervous necrosis virus reshapes ceramide metabolism and uses ceramide accumulation to support replication. The results connect three ceramide-producing pathways with virus-induced autophagy and identify C16-ceramide as a functional mediator, providing a mechanistic framework for antiviral research in aquaculture.
-
Honokiol-Induced Paraptosis in Acute Promyelocytic Leukemia
2026-09-01
The reference study shows that honokiol can kill NB4 acute promyelocytic leukemia cells through paraptosis-like, caspase-independent damage rather than conventional apoptosis. Its mechanistic contribution is to connect endoplasmic reticulum stress, proteasome impairment, mitochondrial injury, mTOR signaling, and MAPK activation while cautioning that LC3 and p62 accumulation alone does not prove autophagy.
-
Calpain, BDNF/TrkB, and Offspring Cognition
2026-08-31
A 2025 Neuropharmacology study links maternal non-obstetric surgery during pregnancy to later offspring cognitive deficits through excessive calpain activity and impaired hippocampal BDNF/TrkB signaling. Its pharmacological rescue experiments with MDL 28170 and a TrkB agonist connect protease dysregulation with synaptic structure, neuronal integrity, and behavior, while also defining important limits for translation.
-
Dacarbazine A2197: Reliable Cytotoxicity Workflows
2026-08-31
This scenario-driven guide explains how Dacarbazine SKU A2197 can support more reproducible viability, proliferation, and cytotoxicity experiments. It connects solvent selection, storage, assay timing, and interpretation to the distinction between relative and fractional viability described in the cited cancer-methods research.
-
PP2A, Autophagy, and Candida Biofilm Resistance
2026-08-30
A 2025 study identifies PP2A, encoded in part by PPH21, as a regulator of autophagy-linked biofilm formation and antifungal resistance in Candida albicans. Through a PPH21 deletion model, rapamycin stimulation, cellular assays, and an oral infection model, the authors connect Atg13 phosphorylation and Atg1 activation with treatment failure in biofilm-associated infection.
-
Matrine Workflows for Thymoma and Inflammation
2026-08-29
Matrine supports a practical, multi-endpoint workflow spanning thymoma stemness, apoptosis, cancer signaling, and inflammatory injury models. This guide connects dose planning with assay controls and troubleshooting while separating published observations from testable mechanistic hypotheses.
-
Cardiogreen for Imaging and Phototherapy
2026-08-28
Cardiogreen, also known as Indocyanine green, connects near-infrared vascular imaging with controlled cell and phototherapy experiments. This guide covers cardiac output measurement, liver blood flow assessment, ophthalmic angiography, and assay designs for apoptosis induction in photodynamic therapy and macrophage-focused tumor studies.
-
Murine RNase Inhibitor for RNA Workflows
2026-08-28
Murine RNase Inhibitor provides oxidation-resistant protection for RT-qPCR, cDNA synthesis, and in vitro transcription when low DTT is preferred. Its defined specificity as an RNase A inhibitor also makes it valuable for troubleshooting nuclease contamination without broadly suppressing unrelated ribonucleases.
-
FMT Reduces Cell Death After Ischemic Stroke
2026-08-27
This rat study links fecal microbiota transplantation with improved neurological function, smaller infarcts, and reduced neuronal apoptosis, necroptosis, and inflammatory microglial activation after ischemic stroke. Its main contribution is a multi-level analysis connecting functional outcomes with RIP1/RIP3/MLKL signaling, apoptotic markers, and iNOS-positive microglia, while also highlighting the need for mechanistic and translational validation.
-
AM 281 and the Translational Logic of CB1 Blockade
2026-08-27
AM 281 offers a selective pharmacological route to interrogate CB1 signaling, astrocytic GLT-1 regulation, glutamate excitotoxicity, and cognitive dysfunction. This thought-leadership guide connects receptor pharmacology with translational strategy for traumatic brain injury, addiction, and memory impairment research.
-
Perphenazine: Dopamine D2 Receptor Antagonist
2026-08-26
Perphenazine is a dopamine D2 receptor antagonist with additional histamine, muscarinic, and adrenergic receptor activity. Research applications include schizophrenia research, opioid tolerance suppression, mitochondria-mediated cell death induction, and host-directed antibacterial studies.
-
Obeticholic Acid Workflows for Liver Research
2026-08-26
Obeticholic Acid enables controlled FXR activation for bile acid homeostasis, hepatocyte gene regulation, and disease-relevant liver phenotyping. This workflow-focused guide connects dose–response experiments with fibrosis and inflammation models while separating established FXR biology from exploratory translational hypotheses.
-
(5Z)-7-Oxozeaenol: TAK1 Inhibitor Workflow
2026-08-25
(5Z)-7-Oxozeaenol provides a selective way to separate TAK1-dependent inflammatory signaling from broader kinase effects. This workflow connects IL-1, NF-κB, JNK/p38 MAPK, COX-2, and metabolic-stress readouts while highlighting controls that improve assay interpretability.
-
FLAG Tag Peptide: From Capture to Translation
2026-08-25
A mechanistic and strategic guide to using the FLAG tag Peptide (DYKDDDDK) for recombinant protein detection, affinity purification, intact complex isolation, and translationally reliable workflows.
-
c-Myc Peptide Workflows for Precision Immunoassays
2026-08-24
Use the c-Myc Peptide as a practical competition control for confirming anti-c-Myc specificity, optimizing tagged fusion-protein assays, and separating true biology from detection artifacts. This workflow also shows how lessons from IRF3 stability research can strengthen assay design without implying that the peptide directly regulates antiviral signaling.